VIKING GLOBAL PERFORMANCE LLC Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for VIKING GLOBAL PERFORMANCE LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of VIKING GLOBAL PERFORMANCE LLC. VIKING GLOBAL PERFORMANCE LLC is a 10% Owner in Arbutus Biopharma Corp ($TKMR) and a 10% Owner in Adaptive Biotechnologies Corp ($ADPT) and a 10% Owner in Axovant Sciences Ltd. ($AXON) and a 10% Owner in Editas Medicine, Inc. ($EDIT) and a 10% Owner in Myovant Sciences Ltd. ($MYOV) and a 10% Owner in BridgeBio Pharma, Inc. ($BBIO) and a 10% Owner in Urovant Sciences Ltd. ($UROV).
Address: 55 RAILROAD AVENUE 3RD FLOOR GREENWICH 06830 CT
Companies in which VIKING GLOBAL PERFORMANCE LLC is an Insider
Adaptive Biotechnologies Corp
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of VIKING GLOBAL PERFORMANCE LLC: 10% Owner
Holdings: 30,993,708 shares
Latest Transaction: Nov 13 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Arbutus Biopharma Corp
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of VIKING GLOBAL PERFORMANCE LLC: 10% Owner
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jan 16 2018
$TKMR Market Capitalization: $138.47M
$TKMR Previous Close: $2.55
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
BridgeBio Pharma, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of VIKING GLOBAL PERFORMANCE LLC: 10% Owner
Holdings: 11,736,137 shares
Latest Transaction: Jun 28 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Editas Medicine, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of VIKING GLOBAL PERFORMANCE LLC: 10% Owner
Holdings: 266,782 shares
Current Value: $4,951,474
Latest Transaction: Feb 08 2016
$EDIT Market Capitalization: $636.78M
$EDIT Previous Close: $18.56
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Myovant Sciences Ltd.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of VIKING GLOBAL PERFORMANCE LLC: 10% Owner
Holdings: 40,765,599 shares
Current Value: $434,968,941
Latest Transaction: Jun 13 2019
$MYOV Market Capitalization: $630.81M
$MYOV Previous Close: $10.67
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Sio Gene Therapies Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of VIKING GLOBAL PERFORMANCE LLC: 10% Owner
Holdings: 105,952,381 shares
Current Value: $1,374,202,382
Latest Transaction: Mar 19 2019
$AXON Market Capitalization: $1.28B
$AXON Previous Close: $12.97
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Urovant Sciences Ltd.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of VIKING GLOBAL PERFORMANCE LLC: 10% Owner
Holdings: 22,848,350 shares
Latest Transaction: Jun 19 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of VIKING GLOBAL PERFORMANCE LLC
Sentiment: All, ADPT, TKMR, BBIO, EDIT, MYOV, AXON, UROV
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 13 2020 | ADPT | Adaptive Biotechno ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Sell | S | 49.52 | 2,500,000 | 123,787,500 | 30,993,708 | 33.5 M to 31 M (-7.46 %) |
| Jan 30 2020 | ADPT | Adaptive Biotechno ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Sell | S | 24.98 | 4,912,899 | 122,706,039 | 33,493,708 | 38.4 M to 33.5 M (-12.79 %) |
| Jun 28 2019 | BBIO | BridgeBio Pharma, ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Option Exercise | C | 0.00 | 50,446,451 | 0 | 0 | |
| Jun 28 2019 | BBIO | BridgeBio Pharma, ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Option Exercise | C | 0.00 | 51,781,276 | 0 | 0 | |
| Jun 28 2019 | BBIO | BridgeBio Pharma, ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 17.00 | 4,705,900 | 80,000,300 | 26,620,991 | 21.9 M to 26.6 M (+21.47 %) |
| Jun 28 2019 | BBIO | BridgeBio Pharma, ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | C | 0.00 | 10,178,954 | 0 | 21,915,091 | 11.7 M to 21.9 M (+86.73 %) |
| Jun 28 2019 | BBIO | BridgeBio Pharma, ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | C | 0.00 | 11,736,137 | 0 | 11,736,137 | 0 to 11.7 M |
View all VIKING GLOBAL PERFORMANCE LLC insider transactions.